Agilent Technologies, Inc. revenue by segment A

Annual Quarterly

Agilent Technologies, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Oct 31, 2025 was Agilent Cross Lab at $2.9 billion, 42% of the total. By sales mix, the largest line in fiscal 2025, which ended Oct 31, 2025 was Non Instrumentationand Other at $4.5 billion, 65% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Jul 31, 2026	FY 2025 Oct 31, 2025	FY 2024 Oct 31, 2024	FY 2023 Oct 31, 2023	FY 2022 Oct 31, 2022	FY 2021 Oct 31, 2021	FY 2020 Oct 31, 2020	FY 2019 Oct 31, 2019	FY 2018 Oct 31, 2018	FY 2017 Oct 31, 2017	FY 2016 Oct 31, 2016
Revenue	7,372	6,948	6,510	6,833	6,848	6,319	5,339	5,163	4,914	4,472	4,202
Operating segments
Agilent Cross Lab	3,058 +7.0% share 41.5%	2,908 +5.9% share 41.9%	2,747 +3.4% share 42.2%	2,656 +82.9% share 38.9%	1,452 +6.8% share 21.2%	1,360 -28.4% share 21.5%	1,900 +3.3% share 35.6%	1,840 +8.2% share 35.6%	1,701 +11.1% share 34.6%	1,531 share 34.2%	—
Life Sciences And Diagnostics Markets	2,912 +10.8% share 39.5%	2,726 +10.5% share 39.2%	2,466 -11.3% share 37.9%	2,780 share 40.7%	—	—	—	—	—	—	—
Applied Markets	1,402 +7.8% share 19.0%	1,314 +1.3% share 18.9%	1,297 -7.2% share 19.9%	1,397 share 20.4%	—	—	—	—	—	—	—
Sales mix
Non Instrumentationand Other	4,800 +9.2% share 65.1%	4,521 +8.8% share 65.1%	4,156 +1.6% share 63.8%	4,091 +3.8% share 59.9%	3,941 +7.6% share 57.5%	3,662 +18.5% share 58.0%	3,090 +2.6% share 57.9%	3,013 share 58.4%	—	—	—
Instrumentation	2,572 +7.4% share 34.9%	2,427 +3.1% share 34.9%	2,354 -14.2% share 36.2%	2,742 -5.7% share 40.1%	2,907 +9.4% share 42.5%	2,657 +18.1% share 42.0%	2,249 +4.6% share 42.1%	2,150 share 41.6%	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: A (NYSE)
Fiscal year ends: October 31
Incorporated in: DE
Headquarters: Santa Clara, CA
SEC filer status: Large accelerated filer
SEC CIK: 1090872
Former names: AGILENT TECHNOLOGIES INC (until Sep 16, 2019)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.